Medtronic gains a key approval for Evolut TAVR valves
More patients can now undergo redo TAVR with a Medtronic valve than ever before.
More patients can now undergo redo TAVR with a Medtronic valve than ever before.
When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.
The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA.
ACT-EARLY is testing the hypothesis that treating asymptomatic carriers of a pathogenic TTR variant with the drug acoramidis could delay amyloidosis from developing.
Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.
Gregg Fonarow, MD, discussed the American Heart Association’s stroke guidelines, the growing influence of AI and much more.
While LVOT modification does make these procedures longer, it can help high-risk patients avoid systolic anterior motion.
Researchers believe a new robotic TEE system could improve the long-term health of interventional echocardiographers in addition to several other key benefits.
One of the world’s largest medtech companies could make a major move within the next 18 months. Que Dallara, the current president of Medtronic’s diabetes…
While LVOT modification does make these procedures longer, it can help high-risk patients avoid systolic anterior motion.
The company says the new device was designed to improve image quality, provide additional maneuverability and simplify ablation workflows for electrophysiologists.